###begin article-title 0
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
###end article-title 0
###begin p 1
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 1
###begin p 2
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 77 82 <span type="species:ncbi:9606">women</span>
Germline mutations of the breast cancer associated gene 1 (BRCA1) predispose women to breast and ovarian cancers. BRCA1 is a large protein with multiple functional domains and interacts with numerous proteins that are involved in many important biological processes/pathways. Mounting evidence indicates that BRCA1 is involved in all phases of the cell cycle and regulates orderly events during cell cycle progression. BRCA1 deficiency, consequently causes abnormalities in the S-phase checkpoint, the G2/M checkpoint, the spindle checkpoint and centrosome duplication. The genetic instability caused by BRCA1 deficiency, however, also triggers cellular responses to DNA damage that blocks cell proliferation and induces apoptosis. Thus BRCA1 mutant cells cannot develop further into full-grown tumors unless this cellular defense is broken. Functional analysis of BRCA1 in cell cycle checkpoints, genome integrity, DNA damage response (DDR) and tumor evolution should benefit our understanding of the mechanisms underlying BRCA1 associated tumorigenesis, as well as the development of therapeutic approaches for this lethal disease.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 700 701 700 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 789 790 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 919 924 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1138 1140 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1366 1368 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1627 1629 1623 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1830 1837 1826 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1840 1842 1836 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 2095 2096 2091 2092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2201 2203 2197 2199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 2204 2206 2200 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 2524 2526 2520 2522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 2527 2529 2523 2525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 109 114 <span type="species:ncbi:9606">women</span>
###xml 874 880 <span type="species:ncbi:9606">humans</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
Breast cancer occurs at the highest frequency and is the second leading cause of cancer mortality in western women. Approximately 90% of breast cancers occur sporadically, without known predisposable genetic alterations. The remaining breast cancer cases are inheritable, which may be caused by mutations of tumor suppressor genes, such as the breast cancer associated gene 1 and 2 (BRCA1 and BRCA2), and other unidentified tumor suppressor genes (1-4). BRCA1 was mapped in 1990 (5) and was subsequently cloned in 1994 (6). Germline mutations in BRCA1 have been detected in approximately half of familial breast cancer cases and most cases of combined familial breast/ovarian cancers [reviewed in (2-4)]. BRCA1 mutation carriers have 50-80% risk to develop breast cancer by the age of 70 (7-9). BRCA1 contains 24 exons, encoding a full-length protein of 1863 amino acids in humans and 1812 amino acids in mice (10,11). BRCA1 also encodes for at least two more protein products of smaller size due to alternative splicing (12-15). One of the variants, BRCA1-Delta11, is identical to the full-length form except for the absence of exon 11 (15). The other is BRCA1-IRIS, which is a 1399-residue polypeptide encoded by an uninterrupted open reading frame that extends from codon 1 of the known BRCA1 open reading frame to a termination point 34 triplets into intron 11 (12). BRCA1 full-length form contains multiple functional domains, including a highly conserved N-terminal RING finger, two nuclear localization signals that are located in the exon 11, an 'SQ' cluster between amino acids 1280-1524, and C-terminal BRCT domains (16). BRCA1 interacts directly or indirectly with numerous molecules, including tumor suppressors, oncogenes, DNA damage repair proteins, cell cycle regulators, transcriptional activators and repressors (Table 1) (17). Consistent with this extensive pattern of interaction, loss-of-function mutations of BRCA1 result in pleiotrophic phenotypes, including growth retardation, increased apoptosis, defective DNA damage repair, abnormal centrosome duplication, defective G2/M cell cycle checkpoint, impaired spindle checkpoint and chromosome damage and aneuploidy [reviewed in (18-20)]. These phenotypes are not compatible, at least on the surface, with the tumor suppressor functions assigned to BRCA1. It is therefore proposed that mutations in BRCA1 do not directly result in tumor formation, but instead they cause genetic instability, subjecting cells to a high risk of malignant transformation (21,22).
###end p 4
###begin title 5
GENETIC INSTABILITY ASSOCIATED WITH BRCA1 MUTATIONS
###end title 5
###begin p 6
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 867 872 <span type="species:ncbi:9606">human</span>
One of the important features of BRCA1 associated breast cancer is that it contains a higher degree of aneuploidy than tumors without BRCA1 mutations (23). A cell line, HCC1937, which was derived from a homozygous BRCA1 deficient breast tumor, exhibits a high number of chromosomal gains and losses, homozygous deletion of tumor suppressors p53 and PTEN, and loss of heterozygosity at multiple loci known to be involved in the pathogenesis of breast cancer (24). Furthermore, mammary tumors developed from a mouse model carrying a mammary specific disruption of Brca1 exhibit extensive chromosome aneuploidy (25). Using comparative genomic hybridization (CGH), and spectral karyotyping (SKY), Weaver et al. (26) demonstrated that the genomic instability in these tumors is similar to the pattern of chromosomal gains and losses, and structural abnormalities found in human BRCA1 mutation associated breast cancers. These alterations include the loss of all or a part of chromosome 14, including 14D3, where Rb1 is mapped, loss of p53 and over-expression of ErbB2, c-Myc, p27, cyclin E and cyclin D1, in the majority of tumors, although they were virtually ER-alpha and p16 negative (26,27).
###end p 6
###begin p 7
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 339 354 339 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 334 354 334 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 357 359 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 451 453 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 454 456 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 604 606 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 607 609 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1130 1131 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 1132 1134 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1135 1137 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 1138 1140 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1141 1143 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
The genomic abnormality found in BRCA1 mutant tumors is likely a direct consequence of BRCA1 deficiency, as the chromosome abnormalities also occurred in mouse embryos homozygous for a loss-of-function mutation in Brca1 (28), in the mouse embryonic fibroblast (MEF) cells homozygous for a targeted deletion of Brca1 full-length form (Brca1Delta11/Delta11) (29), and in cultured cells upon acute deletion of Brca1 through Cre-LoxP mediated approaches (30,31). Brca1 deficient cells also exhibited impaired DNA damage repair, centrosome amplification and abnormalities in all major cell cycle checkpoints (19,32). These defects should be responsible for the genetic instability found in BRCA1 mutant cells. As many of important aspects of BRCA1, including its structural feature and mutation spectrum in breast/ovarian cancers, the subcellular and intranuclear localization patterns, its hypothesized role in DNA double- or single-strand break repair, its assembly into DNA repair foci with multiple factors, and ubiquitination-ligase activity of BRCA1-BARD1 heterodimer, have been discussed in depth in a number of recent reviews (1,17-19,33-37) (), here I would like to focus on the current advances regarding the role of BRCA1 in cell cycle progression and its impact on genome integrity and cancer evolution.
###end p 7
###begin title 8
FUNCTIONS OF BRCA1 IN CELL CYCLE CHECKPOINTS
###end title 8
###begin p 9
###xml 364 365 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 396 397 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 661 663 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 664 666 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 673 678 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 712 713 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 744 745 740 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 760 762 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 823 824 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 889 891 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1009 1016 1005 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
The ability to control precisely the ordering and timing of cell cycle events is essential for maintaining genome integrity and preventing mutations that can disrupt normal growth control. Cells treated with DNA damaging agents, such as gamma radiation, ultraviolet (UV) radiation, adriamycin or cisplatin, coordinately arrest their cell cycle progression at the G1-S phase, the S phase and the G2-M phase to allow times for repairing the damage. Cellular machineries that mediate cell cycle arrest are called cell cycle checkpoints, which monitor DNA status and ensure the completion of the previous phase in the cell cycle before advancing to the next phase (38-40). The Brca1 transcripts are induced in late G1 and become maximal after the G1-S checkpoint (41). BRCA1 protein undergoes hyperphosphorylation during late G1 and S, and is transiently dephosphorylated early after M phase (42). BRCA1 is also associated with numerous proteins that may play important functions in all phases of the cell cycle (Table 1). These observations suggest a putative role of BRCA1 in cell cycle regulation. Indeed, recent findings have indicated that BRCA1 is involved in all phases of the cell cycle and plays an important role in coordinating cell cycle progression, which is essential for maintaining genome integrity.
###end p 9
###begin title 10
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
G1/S cell cycle checkpoint
###end title 10
###begin title 11
BRCA1-RB interaction
###end title 11
###begin p 12
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 782 783 782 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1325 1327 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 1501 1510 1501 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 530 535 <span type="species:ncbi:9606">human</span>
Shortly after the cloning of BRCA1, it was found that inhibition of BRCA1 expression with antisense oligonucleotides enhanced growth of normal and malignant mammary cells (43), and that introduction of wild-type BRCA1 into tumor cells inhibited cell proliferation (44). Interestingly, the growth-inhibitory activity associated with BRCA1 expression was only detected in a subset of cell lines tested, including breast and ovarian but not lung or colon cancer cells (44). Although this observation is consistent with the fact that human BRCA1 mutation carriers mainly develop breast and ovarian tumors, a study attributed this inhibitory activity to the presence of RB protein (45). Aprelikova et al. (45) found that only cells carrying wild-type RB were sensitive to BRCA1 induced G1 arrest, while RB-/- cells were not. To provide a molecular basis for this observation, they further showed that BRCA1 interacts with hypophosphorylated RB. Since hypophosphorylated RB interacts with E2F to prevent transcription of downstream genes and inhibits cell proliferation, it is conceivable that binding to BRCA1 keeps RB in the hypophosphorylated state to achieve growth arrest. BRCA1 C-terminal domains (BRCT) also form a complex with two RB-binding proteins, RbAp46 and RbAp48, and histone deacetylases 1 and 2 (HDAC1 and HDAC2) (46). The RB and histone deacetylase complex (HDC) is thought to suppress transcription of E2F-responsive genes, providing additional evidence for growth inhibition through RB (Figure 1A).
###end p 12
###begin title 13
BRCA1-p21 induction
###end title 13
###begin p 14
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 612 621 612 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
Of note, an earlier investigation attributed the growth-inhibitory effect of BRCA1 to p21WAF1/CIP1, a well-known cyclin-dependent kinase inhibitor (47-49). Somasundaram et al. (50) showed that ectopic over-expression of a wild-type, but not a mutant form, of BRCA1 up-regulated p21 expression and prevented cell cycle progression into the S phase. Such an inhibition effect was not observed in p21-/- cells. Because p53 is a major regulator of p21 expression, they also transfected BRCA1 into p53-/- cells and found that the induction of p21 and inhibition of cell growth by BRCA1 did not require wild-type p53 (Figure 1B).
###end p 14
###begin title 15
ATM-BRCA1/BARD1-p53-p21 axis
###end title 15
###begin p 16
###xml 109 110 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 1014 1015 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1453 1454 1453 1454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1558 1559 1558 1559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1650 1659 1650 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
Contrasted to the above finding, a recent study provided evidence that p53 is involved in the BRCA1 induced G1/S cell cycle checkpoint. It was shown that BRCA1 always forms a heterodimer with BARD1, a BRCA1 associated RING domain protein, in vivo, and the heterodimerization is required to maintain their stability (37,51). Using small interfering RNA (siRNA) to deplete BRCA1 or BARD1, Fabbro et al. (52) demonstrated that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated and Rad3-related)-mediated phosphorylation of p53 at Ser-15 following IR or UV radiation-induced DNA damage. This study had several interesting findings. First, the dependence of p53(Ser-15) phosphorylation on the BRCA1-BARD1 complex is quite unique, as phosphorylation of a number of other ATM/ATR targets including H2AX, Chk2, Chk1 and c-jun does not depend on the presence of BRCA1-BARD1 complex. Second, although both IR and UV radiation-induced p53(Ser-15) phosphorylation, only IR radiation could induce G1/S arrest, while UV radiation did not. Because rapid IR-induced phosphorylation of downstream targets is catalyzed by ATM, while ATR mediates rapid UV induced phosphorylation, this observation suggests that the BRCA1-BARD1 complex mediates ATM, but not ATR, catalyzed p53(Ser-15) phosphorylation. Lastly, they demonstrated that the inhibition of p53(Ser-15) phosphorylation by BRCA1-BARD1 acute suppression compromises p21 induction and G1/S checkpoint arrest. Thus, this study reveals an important role of p21 in mediating BRCA1 function in G1/S arrest by IR radiation, and the induction of p21 transcription requires p53 activation (Figure 1C).
###end p 16
###begin p 17
###xml 112 113 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 639 640 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 912 913 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
A prediction from these observations is that the absence of BRCA1 might decrease p21 expression and impair the G1/S cell cycle checkpoint. However, inconsistently, BRCA1-null embryos exhibited increased levels of p21 and cellular proliferation defects, and died at early postgastrulation stages (28). This is perhaps due to p53 activation triggered by un-repaired DNA damage and genetic instability. Consistently, BRCA1-null embryos survived 1-2 days longer in a p53-null or p21-null genetic background (28,29,53,54). Thus, the activation of p53 triggered by genetic instability in BRCA1-/- embryos obscures the functions of BRCA1 in the G1/S cell cycle checkpoint. It was shown previously that MEF cells carrying double mutations of BRCA1 and p53 were defective at the G1/S cell cycle checkpoint (29). However, this defect cannot be attributed to BRCA1 deficiency, as the absence of p53 alone could impair the G1/S cell cycle checkpoint (49,55).
###end p 17
###begin p 18
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 348 349 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 459 460 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">57</xref>
###xml 665 666 665 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 695 704 695 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1D</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Interestingly, a recent study using primary fibroblasts from human BRCA1 heterozygotes (BRCA1+/-) and wild-type (BRCA1+/+) indicated that UV radiation could induce G1/S cell cycle arrest in BRCA1+/+ cells, while BRCA1+/- cells displayed an moderate impaired G1/S cell cycle checkpoint (56). Because UV radiation does not activate the p53 mediated G1/S cell cycle checkpoint (52), this study provides an example that reduced dose of BRCA1 could attenuate the G1/S arrest in cells where p53 is not activated. UV induced phosphorylation is primarily mediated by ATR, which has been shown to interact with BRCA1 (57). However, it remains unclear how BRCA1 induces the G1/S arrest upon UV radiation (Figure 1D).
###end p 18
###begin p 19
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 217 225 217 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
In summary, BRCA1 induced G1/S arrest may occur through a number of distinct pathways that involve many important BRCA1 interacting proteins, including ATM, ATR, BARD1, RB, p53 and p21 and their downstream effectors (Figure 1).
###end p 19
###begin title 20
S phase cell cycle checkpoint
###end title 20
###begin p 21
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58">58</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
###xml 735 740 735 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Another cell cycle checkpoint induced by ionizing radiation is the S-phase checkpoint, which primarily represents an inhibition of replication initiation upon the DNA damage. A lack of an IR-induced S-phase checkpoint results in persistent DNA synthesis [radioresistant DNA synthesis (RDS)] at early time points after IR. Studies indicated that cells isolated from A-T patients and Nijmegen breakage syndrome (NBS) patients were defective in this checkpoint (58). However, conflicting results were reported regarding whether BRCA1 plays a role in the S-phase checkpoint. One study reported a normal S-phase checkpoint in the BRCA1-/- HCC1937 cells, but no experimental details were provided to support this claim (59). In contrast, Xu et al. (60,61) found that HCC1937 cells were actually defective in S-phase checkpoint, exhibiting a RDS similar to that displayed by AT mutant and NBS mutant cells. Furthermore, their data indicated that the defective IR-induced S-phase checkpoint in HCC1937 cells could be overcome by reconstitution of a wild-type BRCA1, which confirms a role of BRCA1 in this checkpoint.
###end p 21
###begin title 22
ATM-BRCA1 interaction
###end title 22
###begin p 23
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b63">63</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
BRCA1 is phosphorylated at several serine sites, including Ser-988, -1387, -1423, -1497 and -1524 upon IR radiation (62,63). To explore whether one of these sites was an important determinant of the IR-induced S-phase checkpoint, mutations of some of these sites were introduced into BRCA1 and tested in HCC1937 cells. Data indicated that wild-type BRCA1 and BRCA1 constructs mutated at either Ser-1423 or both Ser-1423 and Ser-1524 all complemented the defective IR-induced S-phase checkpoint in HCC1937 cells. In contrast, transfection of a construct bearing a mutation at Ser-1387 of BRCA1 failed to complement this defect (61). Because the Ser-1387 in BRCA1 is a known target of ATM phosphorylation, this finding indicates that the phosphorylation of Ser-1387 in BRCA1 is specifically required for the ATM-mediated S-phase checkpoint after ionizing irradiation.
###end p 23
###begin title 24
ATR-BRCA1 interaction
###end title 24
###begin p 25
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
Evidence has also been presented that BRCA1 is involved in the S-phase checkpoint activated by stalled replication forks, which can be induced by treatment of cells with UV or hydroxyurea (HU). It has been shown that ATR and ATM phosphorylate BRCA1 on several distinct and overlap Ser/Thr residues, including Ser-1423 (62-64). Tibbetts et al. (64) demonstrated that increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser-1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser-1423 phosphorylation. Furthermore, the dramatic relocalization of ATR nuclear foci in response to DNA damage overlaps with the nuclear foci formed by BRCA1. Thus, ATR directly phosphorylates BRCA1 in response to damaged DNA or stalled DNA replication, and both proteins are likely the components of the same genotoxic stress-responsive pathway. These results suggest that ATR activates the intra-S checkpoints in response to stalled replication forks in a manner analogous to that of ATM-dependent induction of these checkpoints after exposure to IR.
###end p 25
###begin p 26
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">65</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
BRCA1 also interacts with several other proteins that play an essential role in the S-phase checkpoint. These include the mediator of DNA damage checkpoint protein 1 (MDC1), H2AX, p53 binding protein 1 (53BP1) and MRE11/RAD50/NBS1 (MRN), which form nuclear foci upon IR radiation and arrest cells in the S phase (65). In addition, Durant and Nickoloff (66) have also proposed a cell-cycle-dependent model in which DNA-PK inhibits replication protein A in the S phase of the cell cycle, while BRCA1 inhibits the exonuclease activity of the MRN complex and facilitates DNA repair and S phase arrest.
###end p 26
###begin title 27
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
G2/M cell cycle checkpoint
###end title 27
###begin p 28
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 418 433 418 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 413 433 413 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 446 451 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 454 456 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 685 700 677 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 680 700 672 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 1059 1074 1039 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 1054 1074 1034 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 1193 1194 1165 1166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1287 1288 1259 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In addition to the G1/S cell cycle checkpoint and the S phase cell cycle checkpoint, IR radiation also activates the G2/M cell cycle checkpoint, which rapidly delays movement of G2 cells into the mitosis (M) phase. Loss of this checkpoint allows cells with damaged DNA to proceed into the M phase, increasing the likelihood of abnormal chromosomes being passed to the daughter cells. Using MEF cells derived from Brca1Delta11/Delta11 embryos, Xu et al. (15) investigated whether the absence of BRCA1 would affect this cell cycle checkpoint. Their data indicated that BRCA1 wild-type cells exhibited a sharp reduction in mitotic index within 1-4 h after IR radiation. In contrast, Brca1Delta11/Delta11 cells showed no reduction in mitotic index upon IR radiation during the same period of the time. The lack of an immediate mitotic delay following gamma-irradiation indicates that elimination of full-length BRCA1 abolishes this checkpoint. They also treated cells with UV radiation and methyl methanesulfonate (MMS). Their data indicated that UV treated Brca1Delta11/Delta11 cells showed a dramatic reduction in mitotic index, while the MMS treated mutant cells were largely defective in the G2/M cell cycle checkpoint. Taken together, these observations suggest that the defect in the G2/M cell cycle checkpoint is specific to certain types of DNA damage.
###end p 28
###begin title 29
BRCA1-Chk1 interaction
###end title 29
###begin p 30
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67">67</xref>
###xml 447 448 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b68">68</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b69">69</xref>
###xml 769 770 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 846 854 846 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
BRCA1 interacts with many proteins that play a role in cell cycle progression (Table 1). It is important to determine whether any BRCA1 interacting proteins are involved in this process, and how they affect the G2/M cell cycle checkpoint in relation to BRCA1. Yarden et al. (67) provided a significant advance on this issue, showing that BRCA1 regulates the expression, phosphorylation and cellular localization of Chk1, a known regulator of the G2-M cell cycle checkpoint. Their data also indicated that BRCA1 affects the expression of both Wee1 kinase, an inhibitor of Cdc2/cyclin B kinase, and the 14-3-3 family of proteins that sequesters phosphorylated Cdc25C and Cdc2/cyclin B kinase in the cytoplasm (68,69). Thus BRCA1 regulates key effectors that control the G2/M checkpoint and is therefore involved in regulating the onset of mitosis (Figure 2).
###end p 30
###begin title 31
BRCA1-ATM interaction
###end title 31
###begin p 32
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b70">70</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">57</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 452 453 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
###xml 679 680 679 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
The chain of the DNA damage response (DDR) starts with upstream kinases, ATM and ATR, which phosphorylate DNA damage sensors, Chk1 and Chk2, and play important roles in the G2/M cell cycle checkpoint (70). ATM, ATR and Chk2 also interact with and phosphorylate BRCA1 (57,62-64). It was revealed that the phosphorylation of BRCA1 by ATM is required for activation of the G2/M checkpoint using the HCC1937 cells, which are defective in both S phase and G2/M cell cycle checkpoints (60,61). In their effort to distinguish the role BRCA1 Ser-1387 and Ser-1423 in these cell cycle checkpoints, they found that mutation of BRCA1 Ser-1423 abolished the ability of BRCA1 to mediate the G2/M checkpoint, while mutation of BRCA1 Ser-1387 affected S phase function of BRCA1 upon IR radiation (60,61). These results clarify the cell cycle checkpoint roles for each of these phosphorylation products.
###end p 32
###begin title 33
BRCA1-Chk2 interaction
###end title 33
###begin p 34
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">71</xref>
###xml 469 474 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 477 479 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">72</xref>
###xml 572 583 568 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S971A/S971A</sup>
###xml 567 583 563 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>S971A/S971A</sup></italic>
###xml 884 895 876 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S971A/S971A</sup>
###xml 879 895 871 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>S971A/S971A</sup></italic>
###xml 1318 1329 1310 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S971A/S971A</sup>
###xml 1313 1329 1305 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>S971A/S971A</sup></italic>
###xml 1383 1384 1375 1376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1454 1455 1446 1447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1604 1612 1596 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 524 529 <span type="species:ncbi:10090">mouse</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 848 856 <span type="species:ncbi:104163">e. gamma</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
Chk2, which is an immediate phosphorylation target of ATM, phosphorylates and co-localizes with BRCA1 within discrete nuclear foci prior to DNA damage by gamma-irradiation (71). Phosphorylation of BRCA1 at serine 988 is required for the release of BRCA1 from Chk2. This phosphorylation is also important for the ability of BRCA1 to restore survival after DNA damage in the BRCA1-mutated cell line HCC1937. To study the impact of Ser-988 mutation on BRCA1 function, Kim et al. (72) mutated the equivalent serine (Ser-971) in mouse Brca1 using a knock-in approach. The Brca1S971A/S971A mice were developmentally normal, however they suffered a moderately increased risk of spontaneous tumor formation, with a majority of females developing uterus hyperplasia and ovarian abnormalities at two years of age. After treatment with DNA damaging agents, i.e. gamma-irradiation and MNNG, Brca1S971A/S971A mice exhibited several abnormalities, including increased body weight, abnormal hair growth pattern, lymphoma, mammary tumor and endometrial tumor. In addition, the onset of tumor formation became accelerated with 80% of mutant mice developing tumors at 1 year of age. These observations suggest that Chk2 phosphorylation of Ser-971 is involved in Brca1 function in modulating DDR and repressing tumor formation. The Brca1S971A/S971A mutant cells also exhibited a partially loss of the G2/M cell cycle checkpoint upon IR radiation. This study suggests that G2/M checkpoint regulation of BRCA is partly modulated by Chk2 phosphorylation in addition to other factors, such as ATM and Chk1 as reviewed earlier (Figure 2).
###end p 34
###begin title 35
BRCA1-Aurora interaction
###end title 35
###begin p 36
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">73</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b76">76</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b77">77</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b83">83</xref>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b84">84</xref>
###xml 712 720 712 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aurora-A</italic>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b85">85</xref>
###xml 904 912 901 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aurora-A</italic>
###xml 1222 1230 1219 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aurora-A</italic>
###xml 1340 1348 1337 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aurora-A</italic>
###xml 1453 1464 1450 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-Aurora</italic>
###xml 1770 1781 1767 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-Aurora</italic>
###xml 1874 1875 1871 1872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 687 702 <span type="species:ncbi:10090">transgenic mice</span>
###xml 858 865 <span type="species:ncbi:9031">chicken</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1303 1308 <span type="species:ncbi:10090">mouse</span>
###xml 1401 1426 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 1428 1432 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1453 1457 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1595 1599 <span type="species:ncbi:10090">mice</span>
###xml 1770 1774 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1782 1797 <span type="species:ncbi:10090">transgenic mice</span>
Aurora-A is one of three serine/threonine kinases (A, B and C) and is known to regulate mitotic progression in various organisms [reviewed in (73-76)]. Aurora-A is frequently amplified in several human cancers and over-expression of Aurora-A has been detected in 94% of invasive duct adenocarcinomas of the breast (77-83). It was recently shown that Aurora-A physically binds and phosphorylates BRCA1 at S308, and the phosphorylation is correlated with impaired function of BRCA1 in regulating G2/M transition (84). This finding suggests a link between Aurora-A over-expression and impaired BRCA1 function in genetic instability and tumorigenesis. However, it was recently reported that transgenic mice carrying Aurora-A over-expression in the mammary gland did not develop mammary tumors although they all exhibited mammary hyperplasia (85). In that study, chicken beta-actin promoter was linked to the Aurora-A gene through a stopper sequence. The transgene is not expressed unless the stopper is deleted by WAP-Cre, which is activated by pregnancy hormones. Because all the mice only went through one full-cycle of pregnancy, it is possible that the deletion of the stopper, which is required for the expression of the Aurora-A transgene, was incomplete. To test this, we have generated a transgenic mouse strain that over expresses the Aurora-A in the mammary epithelium using the promoter of the mouse mammary tumor virus (MMTV). We found that the MMTV-Aurora transgene is expressed at high levels during the mammary cycle of development and induces mammary tumor formation in about 50% of mice with an average latency of 20 months (X. Wang and C. X. Deng, unpublished data). Further investigations are required to determine whether or not the tumorigenesis in the MMTV-Aurora transgenic mice is entirely or partly due to the impaired BRCA1 function in regulating the G2/M cell cycle checkpoint.
###end p 36
###begin title 37
Other BRCA1 interacting proteins
###end title 37
###begin p 38
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b86">86</xref>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 407 408 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b87">87</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b88">88</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b89">89</xref>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b89">89</xref>
###xml 958 959 958 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 696 701 <span type="species:ncbi:9606">human</span>
Upon UV radiation, BRCA1 is phosphorylated on Ser-1423 and Ser-1524 by ATR (86). It was shown previously that BRCA1 mutant MEF cells exhibited a normal G2/M cell cycle checkpoint upon UV radiation (15), suggesting that phosphorylation of BRCA1 by ATR may not have a direct impact on this checkpoint. This observation, however, does not rule out a possibility that ATR may play a role in the BRCA1-mediated G2/M checkpoint through other mechanisms. For example, the genetic interplay between BRCA1 and ATR in the G2/M cell cycle checkpoint could occur in their common downstream genes, such as Chk1. In addition, it was shown that BRIT1 (BRCT-repeat inhibitor of hTERT expression), a repressor of human telomerase function that is implicated in cellular immortalization (87,88), is required for the expression of BRCA1, NBS1 and Chk1 (89). Lin et al. (89) found that when BRIT1 expression is depleted by RNAi, cells exhibited defects in both the S phase and G2/M cell cycle checkpoints and become IR radiation sensitive. Thus, the checkpoint defects in the absence of BRIT1 are likely to result from its regulation of Nbs1, BRCA1 and Chk1.
###end p 38
###begin title 39
The spindle checkpoint
###end title 39
###begin p 40
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b90">90</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b93">93</xref>
###xml 1582 1591 1582 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1831 1840 1831 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1930 1932 1930 1932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b94">94</xref>
###xml 1933 1935 1933 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b96">96</xref>
###xml 2051 2053 2051 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b97">97</xref>
###xml 2317 2319 2317 2319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b98">98</xref>
###xml 2320 2322 2320 2322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b99">99</xref>
###xml 357 362 <span type="species:ncbi:9606">human</span>
###xml 2075 2080 <span type="species:ncbi:10090">mouse</span>
During the mitotic phase, duplicated DNA is first condensed and packed to form sister chromatids, which are then equally separated into newly formed daughter cells. Any premature or mis-separation of sister chromatids will lead to the loss or gain of chromosomes in daughter cells, leading to aneuploidy, which is a prevalent form of genetic instability of human cancers (40). The spindle checkpoint ensures the astonishing accuracy of chromosome segregation by preventing cells with unaligned chromosomes from exiting mitosis. Molecular components of the spindle checkpoint include two evolutionarily conserved protein families, Mad (Mad1, Mad2, Mad3/BubR1) and Bub (Bub1, Bub2, Bub3), as well as other components [reviewed in (90-93)]. In the metaphase, the sister chromatids attach to the mitotic spindle at kinetochores that consist of protein complexes associated with centromeric DNA. After all sister chromatids have attached to the bipolar spindle and their kinetochores are under tension, a large ubiquitin ligase called the anaphase-promoting complex (APC) and its associated substrate-binding co-factor, Cdc20, are activated. The activated APC-Cdc20 tags the securin protein with polyubiquitin chains and promotes its degradation. This, in turn, activates the separase and results in a proteolytic cleavage of the cohesion complex between the sister chromatids and triggers the onset of the anaphase. The spindle checkpoint monitors the attachment of sister chromatids to the spindle and is activated by the lack of microtubule occupancy and tension at the kinetochores (Figure 3A). During the process of spindle checkpoint activation, transient interaction between BubR1-Bub3-Cdc20 and Mad2-Cdc2 complex leads to the formation of the BubR1-Bub3-Mad2-Cdc20 complex (the MCC), which is a more efficient inhibitor of APC (Figure 3B). A number of investigations revealed an essential role of Mad2 in the MCC [reviewed in (94-96)]. Consistently, microinjection of Mad2 antibodies yields premature anaphase onset and chromosome mis-segregation (97). Absence of Mad2 in mouse embryos resulted in accumulation of mitotic errors and apoptosis, leading to early lethality at E5-E6, while haploinsufficiency of Mad2, which results in about 30% less of Mad2 protein, provokes lung tumors after a long latency period (98,99).
###end p 40
###begin p 41
###xml 14 29 14 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 9 29 9 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 67 72 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 75 77 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 236 251 228 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C and D</xref>
###xml 392 395 384 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b100">100</xref>
###xml 877 886 869 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3E</xref>
###xml 950 959 942 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3F</xref>
Studying Brca1Delta11/Delta11 cells during the mitotic phase, Wang et al. (31) found that about 30% of these cells displayed abnormal chromosomes, including chromosome bridging, lagging chromosomes in metaphase, anaphase and telophase (Figure 3C and D). It has been shown that a single unattached kinetochore is sufficient to activate the spindle checkpoint and arrest the cell at metaphase (100). Thus, the observations that  cells exhibited abnormal chromosome behavior and could advance to the anaphase and telophase suggest that the spindle checkpoint is defective. This notion was confirmed by their further experiment, in which the  cells were treated with nocodazole, a reagent that depolymerizes microtubules and activates the spindle checkpoint. Their data indicated that about 60% Brca1 wild-type cells were arrested at metaphase 12 h after the nocodazole treatment (Figure 3E), while Brca1 mutant cells failed to undergo metaphase arrest (Figure 3F), and died due to apoptosis.
###end p 41
###begin p 42
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 35 50 35 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 275 277 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b94">94</xref>
###xml 278 280 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b97">97</xref>
###xml 281 284 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b101">101</xref>
###xml 292 297 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 442 445 434 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b102">102</xref>
Accompanied by these defects, Brca1Delta11/Delta11 cells also displayed decreased expression of a number of genes that are involved in the spindle checkpoint, including Mad2, Polo-like-Kinase, Bub1, BubR1 and ZW-10. Given the critical role of Mad2 in the spindle checkpoint (94,97,101), Wang et al. (31) further addressed the possible interaction between Brca1 and Mad2. Using a tetracycline-regulated system to express BRCA1 in UBR60 cells (102), they demonstrated that BRCA1 positively regulates Mad2 by interacting with its promoter. Furthermore, over-expression of Mad2 in mutant cells partially overcame the spindle checkpoint defects. These observations provide strong evidence that Brca1 plays an important role in the spindle checkpoint through maintaining Mad2 expression.
###end p 42
###begin p 43
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b103">103</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
A similar finding was made in BRCA1 wild-type human prostate (DU-145) and breast (MCF-7) cancer cells upon acute suppression of BRCA1 using small interfering RNA that is specific to BRCA1. In these cells, Bae et al. (103) demonstrated that attenuation of the mitotic cell cycle checkpoint was accompanied by down-regulation of multiple genes implicated in the mitotic spindle checkpoint (e.g. Bub1, Bub1b, He, Stk6 and Birc5). Interestingly, their data also revealed expression changes of many other genes that are involved in chromosome segregation (Espl1, Nek2, Pttg1, multiple kinesis and kinesis-like proteins), centrosome function (ASP), cytokinesis (Prc1, Plk, Mphosph1 and Knsl2), and the transition into and progression through mitosis (B-type cyclins, Cdc2 and Cdc20). BRCA1 knockdown also caused the accumulation of binucleated and multinucleated cells, suggesting a defect in the coordination of cytokinesis and karyokinesis. These findings suggest that BRCA1 transcriptionally regulates gene expression for orderly mitotic progression.
###end p 43
###begin title 44
DDR AND CANCER EVOLUTION
###end title 44
###begin p 45
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 295 300 295 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Co/Co</sup>
###xml 290 309 290 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1<sup>Co/Co</sup>;MMTV-Cre</italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b104">104</xref>
###xml 828 831 828 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b105">105</xref>
###xml 1121 1124 1117 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b106">106</xref>
###xml 1125 1128 1121 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b107">107</xref>
###xml 301 305 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Early attempts to create animal models for BRCA1 associated breast cancer were not successful, as BRCA1 deficiency invariably results in embryonic lethality, primarily due to elevated cell death and growth retardation (28,29). An animal model carrying mammary specific disruption of BRCA1 (BRCA1Co/Co;MMTV-Cre) also exhibited increased apoptosis and abnormal mammary branch morphogenesis before tumor formation at low frequency with long latency (25). Why do BRCA1 deficient cells die? Mounting experimental evidence indicates that organisms have acquired anti-proliferative and cell death-inducing mechanisms that prevent clonal expansion of mutant cells (104). A key mechanism is the DDR, which can be activated not only by DNA damage but also by some other conditions, such as oncogene expression, loss of tumor suppressors (105). Recently, it was shown that during the early cancerous development of lung or bladder tumors, oncogene induced aberrations in DNA replication activates DDR, as evidenced by the posphorylation of H2AX (gammaH2AX) followed by the activation of ATM-Chk2-p53 signaling in the tumor tissues (106,107). The progression to malignant transformation requires the inactivation of DDR, which would in turn create genetic instability and accelerate cancer evolution.
###end p 45
###begin p 46
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 540 555 540 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 535 555 535 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 593 595 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 705 706 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 743 758 735 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 738 758 730 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 781 783 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 811 826 795 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 830 833 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 806 833 790 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup>;p53<sup>+/&#8722;</sup></italic>
###xml 937 940 913 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b108">108</xref>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
Does BRCA1 deficiency activate DDR and thereby cause growth arrest and/or apoptosis? Several lines of evidence indicate that it may be the case. It was shown that the death of BRCA1 mutant cells is directly linked to the activation of p53, as deletion of p53 and/or its downstream mediator p21 partially rescues BRCA1-null embryos (28,29,53,54). Moreover, it was shown that elimination of either one or both wild-type p53 alleles completely overcame embryonic lethality caused by the targeted deletion of full-length Brca1 and allowed Brca1Delta11/Delta11 mutant mice to survive to adulthood (29). Further analysis indicated that haploid loss or complete loss of p53 resulted in attenuated apoptosis and G1-S checkpoint control, allowing Brca1Delta11/Delta11 cells to proliferate (29). Interestingly, most Brca1Delta11/Delta11;p53+/- male mice suffered premature aging, exhibiting higher expression levels of p53 compared with controls (108). This suggests that remaining wild-type p53 is activated, which may be a cause for premature aging.
###end p 46
###begin p 47
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b109">109</xref>
###xml 239 244 239 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Co/Co</sup>
###xml 234 253 234 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1<sup>Co/Co</sup>;MMTV-Cre</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 942 951 942 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/+</sup>
###xml 937 951 937 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/+</sup></italic>
###xml 1199 1214 1195 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11/&#916;11</sup>
###xml 1194 1214 1190 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11/&#916;11</sup></italic>
###xml 1425 1428 1413 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b110">110</xref>
###xml 1687 1695 1675 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 245 249 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
It has been reported that over 90% of human BRCA1 deficient breast cancers also bear p53 mutations, while p53 alterations are only found in about 40% sporadic breast cancers (109). Furthermore, most of mammary tumors developed in the BRCA1Co/Co;MMTV-Cre mouse model also spontaneously mutated their p53 (25), suggesting that the loss of p53 may be responsible for tumorigenesis. To directly test the role of p53 in BRCA1 associated tumorigenesis, a p53-null mutation allele was introduced into BRCA1 conditional mutant model, and the data indicated that introduction of a p53-null mutation into these mice can significantly accelerate mammary tumor formation (25). This data indicated that inactivation of p53 and Brca1 deficiency synergistically induce mammary tumor formation. However the factors responsible for p53 activation in the absence of Brca1 are poorly understood. To investigate this, we employed a genetic test by crossing Brca1Delta11/+ mice with mutant mice carrying targeted mutations of genes in the DDR pathway, including ATM, Chk1, Chk2, p19, Pten, Parp-1, p21 and Gadd45. Our data indicated that ATM or Chk2 inactivation is equivalent to p53 inactivation in that it allows Brca1Delta11/Delta11 embryos to survive to adulthood (L. Cao and C. X. Deng unpublished data). An earlier investigation also revealed that Brca1 deficiency resulted in Chk2 phosphorylation and the Chk2-dependent activation of p53 (110). These observations support a model indicating that BRCA1 deficiency results in genetic instability, leading to the activation of ATM-Chk2-p53 DDR signaling, which, in turn, serves as a natural barrier against malignant transformation of BRCA1 mutant cell (Figure 4).
###end p 47
###begin p 48
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Experimental data also indicate that the inactivation of DDR is not sufficient for Brca1 deficient cells to undergo malignant transformation. Brca1 mutant mice in either a p53 or Chk2 mutant genetic background developed tumors in a stochastic fashion, suggesting additional factor(s) is needed to tumorigenesis. Consistent with this notion, it has been demonstrated that BRCA1 associated tumors are frequently associated with increased expression of oncogenes, such as cyclin D1, c-Myc and ErbB2, and loss of heterozygosity of tumor suppressor genes (23-27).
###end p 48
###begin title 49
CONCLUSIONS AND FUTURE DIRECTIONS
###end title 49
###begin p 50
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 581 582 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 915 923 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
In this review, I have examined experimental evidence regarding the role of BRCA1 in cell cycle checkpoints, genetic stability and tumorigenesis. BRCA1 deficiency results in defective S phase, G2/M and spindle checkpoints. The defects in these cell cycle checkpoints, combined with abnormal centrosome duplication and defective DNA damage repair could cause genetic instability in BRCA1 deficient cells. The genetic instability, in turn, triggers a series of physiological responses, most promptly the DNA damage response, i.e. activation of ATM-Chk2-p53 signals as manifested by G1/S arrest due to up-regulation of p21, and apoptosis due to the activation of pro-apoptotic signals. On the other hand, the absence of BRCA1 allows further genetic alterations, including further tumor suppressor mutations and activation of oncogenes, which overcomes growth defects and ultimately results in breast cancer formation (Figure 4).
###end p 50
###begin p 51
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b103">103</xref>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mad2</italic>
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mad2</italic>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1186 1189 1186 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b103">103</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1513 1515 1513 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1606 1609 1606 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b111">111</xref>
###xml 1610 1613 1610 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b112">112</xref>
###xml 1883 1886 1883 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b113">113</xref>
###xml 2414 2417 2414 2417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b114">114</xref>
###xml 2418 2421 2418 2421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b116">116</xref>
The examination of the literature also reveals many unanswered questions. First, the role of BRCA1 in the G1/S cell cycle checkpoint needs further scrutiny, as BRCA1 deficient cells exhibit an intact G1/S cell cycle checkpoint. p53 activation has obscured the role of BRCA1 in this checkpoint and further mechanistic studies should overcome this barrier. Second, it has been shown that expression of many genes that are critical for the spindle checkpoint is down regulated in cells carrying a targeted disruption (31) or RNAi mediated acute suppression of BRCA1 (103). However, it is not clear about the potential relationship between BRCA1 and expression of these genes. Even in the most well studied case, the Mad2 gene, whose expression is regulated by BRCA1 in a number of experimental systems, the published data was ambiguous about whether the interaction of BRCA1 with the promoter of Mad2 was direct or indirect (31). Until this is done, the regulatory role of BRCA1 in the spindle checkpoint remains un-established. Third, acute suppression of BRCA1 also causes altered expression of many genes that are involved in chromosome segregation, centrosome function or cytokinesis (103). Although this observation is interesting, the claim that BRCA1 regulates gene expression for orderly mitotic progression is premature unless solid evidence is provided. Fourth, recent investigations demonstrated that some major functions of BRCA1 could be attributed to the heterodimer formed between BRCA1 and BARD1 (35,37). In addition, germline mutations of BARD1 were also found in breast and ovarian cancers (111,112). Thus potential roles of the BRCA1/BARD1 heterodimer in tumor suppression, DNA damage repair, cell cycle checkpoints and regulation of centrosome duplication should be interesting topics for future studies. Finally, current chemoprevention and therapy are suboptimal (113). The knowledge regarding functions of BRCA1 in cell cycle checkpoints, genome integrity, DDR and cancer evolution may facilitate drug screening and better design of therapeutic approaches. Reagents that cause reactivation of cell cycle checkpoints, cell death, defective DNA damage repair and/or promote mutant cells through an lethal mitosis should be favorable in the treatment of BRCA1 associated breast cancer. Some promising data attacking weakness of BRCA1/2 tumors has been provided by a number of recent publications (114-116).
###end p 51
###begin p 52
The authors thank Drs Rui-Hong Wang, Thomas Fishler, Joseph De Soto and Cuiying Xiao for critically reading of the manuscript. This work was supported by the intramural Research Program of National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA. The open access publication charge for this paper has been waived by Oxford University Press.
###end p 52
###begin p 53
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 53
###begin title 54
REFERENCES
###end title 54
###begin article-title 55
The role of the BRCA1 tumor suppressor in DNA double-strand break repair
###end article-title 55
###begin article-title 56
Epidemiology, prevention, and early detection of breast cancer
###end article-title 56
###begin article-title 57
Breast cancer susceptibility genes. BRCA1 and BRCA2
###end article-title 57
###begin article-title 58
Familial non-BRCA1/BRCA2-associated breast cancer
###end article-title 58
###begin article-title 59
Linkage of early-onset familial breast cancer to chromosome 17q21
###end article-title 59
###begin article-title 60
Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene
###end article-title 60
###begin article-title 61
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium
###end article-title 61
###begin article-title 62
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
###end article-title 62
###begin article-title 63
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium
###end article-title 63
###begin article-title 64
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
###end article-title 64
###begin article-title 65
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice
###end article-title 65
###begin article-title 66
Identification of BRCA1-IRIS, a BRCA1 locus product
###end article-title 66
###begin article-title 67
Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b
###end article-title 67
###begin article-title 68
Localization of BRCA1 and a splice variant identifies the nuclear localization signal
###end article-title 68
###begin article-title 69
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
###end article-title 69
###begin article-title 70
BRCA1: a review of structure and putative functions
###end article-title 70
###begin article-title 71
Roles of BRCA1 and its interacting proteins
###end article-title 71
###begin article-title 72
Cancer susceptibility and the functions of BRCA1 and BRCA2
###end article-title 72
###begin article-title 73
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Tumor formation in Brca1 conditional mutant mice
###end article-title 73
###begin article-title 74
###xml 67 71 <span type="species:ncbi:10090">mice</span>
BRCA1-associated tumorigenesis: what have we learned from knockout mice?
###end article-title 74
###begin article-title 75
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice
###end article-title 75
###begin article-title 76
###xml 29 40 <span type="species:ncbi:111938">Gatekeepers</span>
Cancer-susceptibility genes. Gatekeepers and caretakers
###end article-title 76
###begin article-title 77
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
###end article-title 77
###begin article-title 78
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier
###end article-title 78
###begin article-title 79
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
###end article-title 79
###begin article-title 80
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer
###end article-title 80
###begin article-title 81
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
###end article-title 81
###begin article-title 82
###xml 29 35 <span type="species:ncbi:10090">murine</span>
A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability
###end article-title 82
###begin article-title 83
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
###end article-title 83
###begin article-title 84
Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity
###end article-title 84
###begin article-title 85
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
###end article-title 85
###begin article-title 86
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
###end article-title 86
###begin article-title 87
Roles of BRCA1 in centrosome duplication
###end article-title 87
###begin article-title 88
Roles of BRCA1 in DNA damage repair: a link between development and cancer
###end article-title 88
###begin article-title 89
Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking
###end article-title 89
###begin article-title 90
Assessing the link between BACH1 and BRCA1 in the FA pathway
###end article-title 90
###begin article-title 91
The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
###end article-title 91
###begin article-title 92
Cell cycle checkpoints: preventing an identity crisis
###end article-title 92
###begin article-title 93
Cell-cycle checkpoints and cancer
###end article-title 93
###begin article-title 94
On the road to cancer: aneuploidy and the mitotic checkpoint
###end article-title 94
###begin article-title 95
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells
###end article-title 95
###begin article-title 96
BRCA1 is a cell cycle-regulated nuclear phosphoprotein
###end article-title 96
###begin article-title 97
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
###end article-title 97
###begin article-title 98
Growth retardation and tumour inhibition by BRCA1
###end article-title 98
###begin article-title 99
BRCA1-associated growth arrest is RB-dependent
###end article-title 99
###begin article-title 100
BRCA1 interacts with components of the histone deacetylase complex
###end article-title 100
###begin article-title 101
WAF1, a potential mediator of p53 tumor suppression
###end article-title 101
###begin article-title 102
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
###end article-title 102
###begin article-title 103
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
###end article-title 103
###begin article-title 104
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
###end article-title 104
###begin article-title 105
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
###end article-title 105
###begin article-title 106
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage
###end article-title 106
###begin article-title 107
Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation
###end article-title 107
###begin article-title 108
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
###end article-title 108
###begin article-title 109
The tumor suppressor p53
###end article-title 109
###begin article-title 110
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment
###end article-title 110
###begin article-title 111
BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation
###end article-title 111
###begin article-title 112
Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart
###end article-title 112
###begin article-title 113
Genetic analysis of BRCA1 function in a defined tumor cell line
###end article-title 113
###begin article-title 114
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation
###end article-title 114
###begin article-title 115
Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation
###end article-title 115
###begin article-title 116
Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
###end article-title 116
###begin article-title 117
Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization
###end article-title 117
###begin article-title 118
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
###end article-title 118
###begin article-title 119
MDC1 is a mediator of the mammalian DNA damage checkpoint
###end article-title 119
###begin article-title 120
Good timing in the cell cycle for precise DNA repair by BRCA1
###end article-title 120
###begin article-title 121
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
###end article-title 121
###begin article-title 122
Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase
###end article-title 122
###begin article-title 123
14-3-3 proteins: regulation of subcellular localization by molecular interference
###end article-title 123
###begin article-title 124
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
###end article-title 124
###begin article-title 125
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
###end article-title 125
###begin article-title 126
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1
###end article-title 126
###begin article-title 127
Aurora kinases link chromosome segregation and cell division to cancer susceptibility
###end article-title 127
###begin article-title 128
The Aurora kinases: role in cell transformation and tumorigenesis
###end article-title 128
###begin article-title 129
Aurora kinases in spindle assembly and chromosome segregation
###end article-title 129
###begin article-title 130
Aurora A, meiosis and mitosis
###end article-title 130
###begin article-title 131
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
###end article-title 131
###begin article-title 132
Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
###end article-title 132
###begin article-title 133
###xml 15 25 15 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 15 25 <span type="species:ncbi:7227">Drosophila</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
###end article-title 133
###begin article-title 134
###xml 117 122 <span type="species:ncbi:9606">human</span>
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer
###end article-title 134
###begin article-title 135
###xml 44 49 <span type="species:ncbi:9606">human</span>
Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis
###end article-title 135
###begin article-title 136
###xml 63 68 <span type="species:ncbi:9606">human</span>
The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma
###end article-title 136
###begin article-title 137
Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast
###end article-title 137
###begin article-title 138
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition
###end article-title 138
###begin article-title 139
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models
###end article-title 139
###begin article-title 140
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies
###end article-title 140
###begin article-title 141
Multiple tumor suppressor pathways negatively regulate telomerase
###end article-title 141
###begin article-title 142
###xml 85 90 <span type="species:ncbi:9606">human</span>
Identification of microcephalin, a protein implicated in determining the size of the human brain
###end article-title 142
###begin article-title 143
BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly
###end article-title 143
###begin article-title 144
The anaphase-promoting complex: proteolysis in mitosis and beyond
###end article-title 144
###begin article-title 145
Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling
###end article-title 145
###begin article-title 146
Regulation of APC-Cdc20 by the spindle checkpoint
###end article-title 146
###begin article-title 147
The spindle checkpoint
###end article-title 147
###begin article-title 148
Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex
###end article-title 148
###begin article-title 149
Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
###end article-title 149
###begin article-title 150
Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1
###end article-title 150
###begin article-title 151
Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase
###end article-title 151
###begin article-title 152
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2
###end article-title 152
###begin article-title 153
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
###end article-title 153
###begin article-title 154
How cells get the right chromosomes
###end article-title 154
###begin article-title 155
Mad2 phosphorylation regulates its association with Mad1 and the APC/C
###end article-title 155
###begin article-title 156
Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
###end article-title 156
###begin article-title 157
BRCA1 regulates gene expression for orderly mitotic progression
###end article-title 157
###begin article-title 158
Intrinsic tumour suppression
###end article-title 158
###begin article-title 159
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
###end article-title 159
###begin article-title 160
###xml 64 69 <span type="species:ncbi:9606">human</span>
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
###end article-title 160
###begin article-title 161
###xml 67 72 <span type="species:ncbi:9606">human</span>
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
###end article-title 161
###begin article-title 162
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform
###end article-title 162
###begin article-title 163
Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
###end article-title 163
###begin article-title 164
Collaboration of Brca1 and Chk2 in tumorigenesis
###end article-title 164
###begin article-title 165
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Mutational analysis of BARD1 in familial breast cancer patients in Japan
###end article-title 165
###begin article-title 166
Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations
###end article-title 166
###begin article-title 167
The effects of tamoxifen on the female genital tract
###end article-title 167
###begin article-title 168
N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells
###end article-title 168
###begin article-title 169
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
###end article-title 169
###begin article-title 170
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
###end article-title 170
###begin title 171
Figures and Tables
###end title 171
###begin p 172
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 410 411 410 411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 450 451 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 527 528 527 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 574 575 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Current views of BRCA1 functions G1 and G1/S cell cycle checkpoint. (A) A model illustrating a negative role for BRCA1 in G1 arrest. BRCA1 binds to hypophosphorylated RB, which interacts with E2F to form an active complex that blocks transcription. BRCA1 and RB also recruit HDC, which deacetylates histones associated with the promoter, thereby promoting formation of nucleosomes that inhibit transcription. (B and C) Expression of BRCA1 may cause G1/S arrest through a p53-independent (B), and p53 dependent (C) mechanisms. (D) UV radiation may also cause BRCA1-mediated G1/S arrest, although it is not clear whether p21 is involved.
###end p 172
###begin p 173
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 686 687 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 803 804 799 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 969 970 965 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1171 1172 1167 1168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
A model illustrating a role of BRCA1 in the C2/M cell cycle checkpoint. BRCA1 can be phosphorylated by ATR, ATM and Chk2. BRCA1 regulates expression and cellular localization of Chk1, although it is not clear whether Chk1 can phosphorylates BRCA1. Both Chk1 and Chk2 inactivate Cdc25 by phosphorylate it at Ser-216. The phosphorylation of Cdc25 at Ser-126 not only inactivates this protein but also allows it to bind to 14-3-3alpha, leading to its exporting from the nucleus. This results in the decrease of the active form of Cdc25, which is a phosphatase involved in dephosphorylation of Cdc2. The dephosphorylated form of Cdc2 is the active form that promotes cell progression from G2 to M phase. Therefore, the reduced amount of Cdc25 results in the decrease of active form of Cdc2, which prevents G2 to M transition. Another two factors are also involved in this pathway. One is Cyclin B1, which forms an active complex with Cdc2 to promote cell progression from G2 to M phase, and the other is Wee1, a kinase that puts phosphate on an inhibitory site of Cdc2, thereby inhibiting function of Cdc2. Thus, expression changes of these genes could theoretically affect G2/M cell cycle checkpoint.
###end p 173
###begin p 174
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 431 432 431 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 455 462 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 450 462 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11</sup></italic>
###xml 462 463 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 463 470 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 463 470 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#916;11</sup></italic>
###xml 597 598 585 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 603 604 591 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 659 666 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 654 666 642 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11</sup></italic>
###xml 666 667 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 667 674 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 667 674 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#916;11</sup></italic>
###xml 733 740 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 728 740 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1<sup>&#916;11</sup></italic>
###xml 740 741 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 741 748 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;11</sup>
###xml 741 748 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#916;11</sup></italic>
The spindle checkpoint, activation and deficiency. (A) A bipolar spindle showing an unattached kinetochore (arrow). (B) The activation of the spindle checkpoint at the kinetochore leads to the formation of the BubR1-Bub3-Mad2-Cdc20 complex (MCC). The MCC binds and inhibits activity of PPC, preventing sister chromatids from separation. It is shown that Brca1 interacts with Mad2 promoter and positively regulates its expression. (C and D) Images of Brca1Delta11/Delta11 (C) and wild-type (D) MEF cells stained with Dapi and an anti-alpha-tubulin antibody. Arrows pointed to lagging chromosomes. (E and F) Morphology difference between wild-type (E) and Brca1Delta11/Delta11 MEF (F) cells in responding to nocodazole treatment. Brca1Delta11/Delta11 MEF cells at mitotic phase (as revealed by both round up and positive for phosphorylated histone H3 antibody staining) exhibited significantly more fragmented cells. Phosphorylated histone H3 antibody staining also indicated that many mutant cells contained fragmented chromosomes.
###end p 174
###begin p 175
A model illustrating connections among cell cycle checkpoints, centrosome duplication, DNA damage repair, genetic instability, DNA damage response, developmental abnormalities and tumorigenesis caused by BRCA1 deficiency.
###end p 175
###begin p 176
A list of BRCA1 interacting proteins
###end p 176

